With Reduced Proneoplastic Potential An Engineered Bivalent Neuregulin Protects Against Doxorubicin-Induced Cardiotoxicity

Steinhauser, Luis M. Alvarez, Joseph Gannon, Calum A. Macrae, Linda G. Griffith and Richard Steven M. Jay, Ashwin C. Murthy, Jessica F. Hawkins, Joshua R. Wortzel, Matthew L. With Reduced Proneoplastic Potential An Engineered Bivalent Neuregulin Protects Against Doxorubicin-Induced Cardiotoxicity Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2013 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/CIRCULATIONAHA.113.002203 2013;128:152-161; originally published online June 11, 2013; Circulation. http://circ.ahajournals.org/content/128/2/152 World Wide Web at: The online version of this article, along with updated information and services, is located on the http://circ.ahajournals.org/content/suppl/2013/06/11/CIRCULATIONAHA.113.002203.DC1.html Data Supplement (unedited) at: